Safety and Immunogenicity of SARS-CoV-2 Vaccines in Patients With Chronic Liver Diseases (CHESS-NMCID 2101): A Multicenter Study
Authors: Jingwen Ai 1, Jitao Wang 2, Dengxiang Liu 3, Huiling Xiang 4, Ying Guo 5, Jet.al. Abstract Background & aims: We aimed to assess the safety and immunogenicity of inactivated whole-virion severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines in patients with chronic liver diseases (CLD) in this study. Methods: This was a prospective, multi-center, open-label study. Participants aged over 18 years with confirmed CLD and […]